What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
This year marks the 10th anniversary of Cancer Discovery, a journal of the AACR. To celebrate the anniversary, Cancer Discovery published a special anniversary issue, featured spotlights on groundbreaking articles on its website, and held the Cancer Discovery ...
The effects of the coronavirus pandemic have rippled through the entire cancer community, from individual patients to the world’s...
As we welcome in August, it’s time to look back at some of the top articles published in the nine AACR journals...
Clinical trials are a crucial part of the cancer research continuum, providing a testing ground for the safety and...
The cover of the inaugural issue of Blood Cancer Discovery, launched in July 2020, does not feature stained tissue...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Cancers that grow and disseminate to threaten life reside...
In recent months, Asians in America have been targets of increasing numbers of verbal insults and physical attacks. While...
For the month of June, the editors of the nine AACR journals highlighted results from two clinical trials, preclinical data on KRAS inhibitors...
Cancer researchers and cancer survivors are often viewed in separate silos. Scientists toil away alone in laboratories to decode the mechanisms of the disease and test novel molecules. Cancer...
Ten years ago, then-President of the AACR, Tyler Jacks, PhD, FAACR, conceived the idea for a “comprehensive, high-impact journal that would present new...